Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy von Gjertsen, B T, Schöffski, P

Volltext

Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia von McCormack, E, Haaland, I, Venås, G, Forthun, R B, Huseby, S, Gausdal, G, Knappskog, S, Micklem, D R, Lorens, J B, Bruserud, Ø, Gjertsen, B T

Volltext

HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia von Kontro, M, Kumar, A, Majumder, M M, Eldfors, S, Parsons, A, Pemovska, T, Saarela, J, Yadav, B, Malani, D, Fløisand, Y, Höglund, M, Remes, K, Gjertsen, B T, Kallioniemi, O, Wennerberg, K, Heckman, C A, Porkka, K

Volltext

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients von Hjorth-Hansen, H, Stentoft, J, Richter, J, Koskenvesa, P, Höglund, M, Dreimane, A, Porkka, K, Gedde-Dahl, T, Gjertsen, B T, Gruber, F X, Stenke, L, Eriksson, K M, Markevärn, B, Lübking, A, Vestergaard, H, Udby, L, Bjerrum, O W, Persson, I, Mustjoki, S, Olsson-Strömberg, U

Volltext

Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients von Mustjoki, S, Richter, J, Barbany, G, Ehrencrona, H, Fioretos, T, Gedde-Dahl, T, Gjertsen, B T, Hovland, R, Hernesniemi, S, Josefsen, D, Koskenvesa, P, Dybedal, I, Markevärn, B, Olofsson, T, Olsson-Strömberg, U, Rapakko, K, Thunberg, S, Stenke, L, Simonsson, B, Porkka, K, Hjorth-Hansen, H

Volltext

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS von Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K., van der Klift, M., van Marwijk Kooy, M., Maertens, J., Michaux, L., van der Poel, M. W. M., van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., van der Velden, W. J. F. M., de Weerdt, O., Pabst, T., Manz, M., Löwenberg, B.

Volltext

Update on the randomised phase Ib/II study of the selective small molecule AXL inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib or pembrolizumab in p... von Schuster, C., Gausdal, G., Gjertsen, B.T., Lorens, J., Straume, O.

Volltext

Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia von Kontro, M, Kuusanmäki, H, Eldfors, S, Burmeister, T, Andersson, E I, Bruserud, Ø, Brümmendorf, T H, Edgren, H, Gjertsen, B T, Itälä-Remes, M, Lagström, S, Lohi, O, Lundán, T, Martí, J M L, Majumder, M M, Parsons, A, Pemovska, T, Rajala, H, Vettenranta, K, Kallioniemi, O, Mustjoki, S, Porkka, K, Heckman, C A

Volltext

Safety and efficacy of the combination of pegylated interferon- alpha 2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients von Hjorth-Hansen, H, Stentoft, J, Richter, J, Koskenvesa, P, Hoglund, M, Dreimane, A, Porkka, K, Gedde-Dahl, T, Gjertsen, B T, Gruber, F X, Stenke, L, Eriksson, K M, Markevaern, B, Luebking, A, Vestergaard, H, Udby, L, Bjerrum, O W, Persson, I, Mustjoki, S, Olsson-Stromberg, U

Volltext

Review: genetic models of acute myeloid leukaemia von McCormack, E, Bruserud, O, Gjertsen, B T

Volltext

Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells von Irish, Jonathan M, Hovland, Randi, Krutzik, Peter O, Perez, Omar D, Bruserud, Øystein, Gjertsen, Bjørn T, Nolan, Garry P

Volltext

Tunneling nanotube (TNT) formation is independent of p53 expression von Andresen, V, Wang, X, Ghimire, S, Omsland, M, Gjertsen, B T, Gerdes, H H

Volltext

Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib Therapy von Thielen, Noortje, Richter, Johan, Baldauf, Matthias, Barbany, Gisela, Fioretos, Thoas, Giles, Francis, Gjertsen, Bjørn-Tore, Hochhaus, Andreas, Schuurhuis, Gerrit Jan, Sopper, Sieghart, Stenke, Leif, Thunberg, Sarah, Wolf, Dominik, Ossenkoppele, Gert, Porkka, Kimmo, Janssen, Jeroen, Mustjoki, Satu

Volltext

Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia von Ånensen, N, Hjelle, S M, Van Belle, W, Haaland, I, Silden, E, Bourdon, J-C, Hovland, R, Taskén, K, Knappskog, S, Lønning, P E, Bruserud, Ø, Gjertsen, B T

Volltext

Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antag... von Hatfield, K J, Hovland, R, Øyan, A M, Kalland, K H, Ryningen, A, Gjertsen, B T, Bruserud, Ø

Volltext

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS von Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K., van der Klift, M., van Marwijk Kooy, M., Maertens, J., Michaux, L., van der Poel, M. W. M., van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., van der Velden, W. J. F. M., de Weerdt, O., Pabst, T., Manz, M., Löwenberg, B.

Volltext

NK cell dynamics and association with molecular response in early chronic phase chronic myelogenous leukemia (CML-CP) patients treated with nilotinib von Sopper, S, Mustjoki, S, Gjertsen, B T, Giles, F, Hochhaus, A, Janssen, J J W M, Porkka, K, Wolf, D

Volltext

In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL von Laukkanen, S, Grönroos, T, Pölönen, P, Kuusanmäki, H, Mehtonen, J, Cloos, J, Ossenkoppele, G, Gjertsen, B, Øystein, B, Heckman, C, Heinäniemi, M, Kontro, M, Lohi, O

Volltext

Animal models of acute myelogenous leukaemia - development, application and future perspectives von MC CORMACK, E, BRUSERUD, Ø, GJERTSEN, B. T

Volltext

Mdm2 controls CREB-dependent transactivation and initiation of adipocyte differentiation von Hallenborg, P, Feddersen, S, Francoz, S, Murano, I, Sundekilde, U, Petersen, R K, Akimov, V, Olson, M V, Lozano, G, Cinti, S, Gjertsen, B T, Madsen, L, Marine, J-C, Blagoev, B, Kristiansen, K

Volltext